Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-08-16
2011-08-16
Aeder, Sean E (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S04400A
Reexamination Certificate
active
07999088
ABSTRACT:
The present invention provides a method of treating cancer by providing to a subject in need thereof an immunogenic composition comprising a nucleic acid construct encoding a polypeptide comprising CTL epitopes PSMA288-297and PRAME425-433, or a cross-reactive analogue. In embodiments of the present invention there is provided methods and compositions for inducing, entraining, and/or amplifying the immune response to MHC class-I restricted epitopes of carcinoma antigens to generate an effective anti-cancer immune response.
REFERENCES:
patent: 5512437 (1996-04-01), Gaugler et al.
patent: 5512444 (1996-04-01), Patard et al.
patent: 5538866 (1996-07-01), Israeli et al.
patent: 5571711 (1996-11-01), van der Bruggen et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5610013 (1997-03-01), Van den Eynde et al.
patent: 5620886 (1997-04-01), Brichard et al.
patent: 5648226 (1997-07-01), Van den Eynde et al.
patent: 5679647 (1997-10-01), Carson et al.
patent: 5683886 (1997-11-01), van der Bruggen et al.
patent: 5747271 (1998-05-01), Boon-Falleur et al.
patent: 5763155 (1998-06-01), Boon-Falleur et al.
patent: 5763165 (1998-06-01), Boon-Falleur et al.
patent: 5801005 (1998-09-01), Cheever et al.
patent: 5804381 (1998-09-01), Chen et al.
patent: 5830753 (1998-11-01), Coulie et al.
patent: 5837476 (1998-11-01), Brichard et al.
patent: 5840839 (1998-11-01), Wang et al.
patent: 5844075 (1998-12-01), Kawakami et al.
patent: 5856136 (1999-01-01), Au-Young
patent: 5858689 (1999-01-01), van der Bruggen et al.
patent: 5874560 (1999-02-01), Kawakami et al.
patent: 5888751 (1999-03-01), Tureci et al.
patent: 5935818 (1999-08-01), Israeli et al.
patent: 5985571 (1999-11-01), Van Baren et al.
patent: 5994523 (1999-11-01), Kawakami et al.
patent: 6013481 (2000-01-01), DeBacker et al.
patent: 6017716 (2000-01-01), Pfreundschuh
patent: 6020134 (2000-02-01), Pfreundschuh
patent: 6022692 (2000-02-01), Coulie et al.
patent: 6025191 (2000-02-01), Pfreundschuh
patent: 6025470 (2000-02-01), Valmori et al.
patent: 6069001 (2000-05-01), Van den Eynde et al.
patent: 6140050 (2000-10-01), Sahin et al.
patent: 6174692 (2001-01-01), Rimoldi et al.
patent: 6200765 (2001-03-01), Murphy et al.
patent: 6274145 (2001-08-01), Chen et al.
patent: 6287756 (2001-09-01), Tureci et al.
patent: 6338947 (2002-01-01), Sahin et al.
patent: 6342221 (2002-01-01), Thorpe et al.
patent: 6417165 (2002-07-01), Valmori et al.
patent: 6548064 (2003-04-01), Tureci et al.
patent: 6605711 (2003-08-01), Valmori et al.
patent: 6660276 (2003-12-01), Slingluff et al.
patent: 6685947 (2004-02-01), Jackson et al.
patent: 6709844 (2004-03-01), Levy
patent: 6720146 (2004-04-01), Stolk et al.
patent: 6746839 (2004-06-01), Duff et al.
patent: 6861234 (2005-03-01), Simard et al.
patent: 6977074 (2005-12-01), Kundig et al.
patent: 6994851 (2006-02-01), Kündig et al.
patent: 7232682 (2007-06-01), Simard et al.
patent: 7252824 (2007-08-01), Simard et al.
patent: 7364729 (2008-04-01), Kundig et al.
patent: 7390654 (2008-06-01), Levy
patent: 7511118 (2009-03-01), Liu et al.
patent: 7511119 (2009-03-01), Liu et al.
patent: 7605227 (2009-10-01), Liu et al.
patent: 2002/0007173 (2002-01-01), Kundig et al.
patent: 2003/0044813 (2003-03-01), Old et al.
patent: 2003/0046714 (2003-03-01), Simard et al.
patent: 2003/0138808 (2003-07-01), Simard et al.
patent: 2003/0165834 (2003-09-01), Chen et al.
patent: 2003/0180298 (2003-09-01), Old et al.
patent: 2003/0180949 (2003-09-01), Levy
patent: 2003/0186355 (2003-10-01), Ossendorp et al.
patent: 2003/0215425 (2003-11-01), Simard et al.
patent: 2003/0220239 (2003-11-01), Simard et al.
patent: 2003/0228634 (2003-12-01), Simard et al.
patent: 2004/0063120 (2004-04-01), Beer et al.
patent: 2004/0132088 (2004-07-01), Simard et al.
patent: 2004/0180354 (2004-09-01), Simard et al.
patent: 2004/0203051 (2004-10-01), Simard et al.
patent: 2004/0253218 (2004-12-01), Eisenbach-Schwartz et al.
patent: 2005/0069982 (2005-03-01), Simard et al.
patent: 2005/0079152 (2005-04-01), Bot et al.
patent: 2005/0118186 (2005-06-01), Chiang et al.
patent: 2005/0130920 (2005-06-01), Simard et al.
patent: 2005/0142144 (2005-06-01), Simard et al.
patent: 2005/0221440 (2005-10-01), Simard et al.
patent: 2005/0260234 (2005-11-01), Simard et al.
patent: 2005/0287068 (2005-12-01), Bot et al.
patent: 2006/0008468 (2006-01-01), Chiang et al.
patent: 2006/0057673 (2006-03-01), Liu et al.
patent: 2006/0063913 (2006-03-01), Liu et al.
patent: 2006/0094661 (2006-05-01), Liu et al.
patent: 2006/0153844 (2006-07-01), Kündig et al.
patent: 2006/0153858 (2006-07-01), Kundig et al.
patent: 2006/0159689 (2006-07-01), Chiang et al.
patent: 2006/0159694 (2006-07-01), Chiang et al.
patent: 2006/0165711 (2006-07-01), Bot et al.
patent: 2006/0269521 (2006-11-01), Levy
patent: 2007/0003563 (2007-01-01), Bot et al.
patent: 2007/0004662 (2007-01-01), Qiu et al.
patent: 2007/0049533 (2007-03-01), Liu et al.
patent: 2007/0060518 (2007-03-01), Liu et al.
patent: 2007/0060524 (2007-03-01), Liu et al.
patent: 2007/0184062 (2007-08-01), Simard et al.
patent: 2007/0269464 (2007-11-01), Simard et al.
patent: 2008/0014211 (2008-01-01), Bot et al.
patent: 2008/0124352 (2008-05-01), Diamond et al.
patent: 2008/0199485 (2008-08-01), Kundig et al.
patent: 2009/0035252 (2009-02-01), Kundig et al.
patent: 2009/0131355 (2009-05-01), Bot et al.
patent: 2009/0148478 (2009-06-01), Chiang et al.
patent: 2009/0208537 (2009-08-01), Simard et al.
patent: 2009/0285843 (2009-11-01), Simard et al.
patent: 564359 (2006-12-01), None
patent: 564360 (2006-12-01), None
patent: WO 97/04802 (1998-02-01), None
patent: WO 98/58956 (1998-12-01), None
patent: WO 99/02183 (1999-01-01), None
patent: WO 99/43801 (1999-09-01), None
patent: WO 00/06723 (2000-02-01), None
patent: WO 00/20027 (2000-04-01), None
patent: WO 01/30382 (2001-05-01), None
patent: WO 01/45728 (2001-06-01), None
patent: WO 01/62776 (2001-08-01), None
patent: WO 01/85932 (2001-11-01), None
patent: WO 01/90197 (2001-11-01), None
patent: WO 02/08716 (2002-01-01), None
patent: WO 02/28429 (2002-04-01), None
patent: WO 02/069907 (2002-09-01), None
patent: WO 02/069907 (2002-09-01), None
patent: WO 02/081646 (2002-10-01), None
patent: WO 02/081646 (2002-10-01), None
patent: WO 02/102299 (2002-12-01), None
patent: WO 03/011331 (2003-02-01), None
patent: WO 03/011332 (2003-02-01), None
patent: WO 03/075952 (2003-09-01), None
patent: WO 03/076585 (2003-09-01), None
patent: WO 2004/018666 (2004-03-01), None
patent: WO 2004/022709 (2004-03-01), None
patent: WO 2004/110485 (2004-12-01), None
patent: WO 2004/112825 (2004-12-01), None
patent: WO 2004/112825 (2004-12-01), None
patent: WO 2005/002621 (2005-01-01), None
patent: WO 2005/010190 (2005-02-01), None
patent: WO 2006/009920 (2006-01-01), None
patent: WO 2006/014579 (2006-02-01), None
Kessler et al., “Efficient Identification of Novel HLA-A (*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis,”Journal of Experimental Medicine, vol. 193, No. 1, pp. 73-88, Jan. 1, 2001.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration dated Dec. 4, 2006 for PCT/US2006/023498.
Bot A, “Potent Immunity Achieved by Targeted Sequential Administration of Recombinant DN Vectors and Anchor-Modified Epitope Peptides,” Scient. Meeting of Int'l Society for Biological Therapy of Cancer. Retrieved from http://ww.isbtc.org/meetings/am05/presentations/bot.pdf (retrieved 2006), 2005.
Bot et al. “A Novel Class of Biotherapeutics Co-Targeting Cancer Cells and the Associated Tumor Neovasculature,” J. of Immunotherapy, 28(6):637, 2005.
Chang, SS. et al., “Prostate-specific Membrane Antigen Is Produced in Tumor-Associated Neovasculature,” Clinical Cancer Research 5(10):2674-2681, 1999.
Fetsch, PA. et al., “Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fi
Bot Adrian Ion
Qiu Zhiyong
Aeder Sean E
Davis , Wright, Tremaine, LLP
MannKind Corporation
LandOfFree
Methods and compositions to elicit multivalent immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions to elicit multivalent immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions to elicit multivalent immune... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2710822